Risk of Major Adverse Cardiovascular Events in Patients With Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Gastroenterology and Hepatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Risk of Major Adverse Cardiovascular Events in Immune-Mediated Inflammatory Disorders on Biologics and Small Molecules: Network Meta-Analysis
Clin. Gastroenterol. Hepatol. 2024 May 01;22(5)961-970.e12, SS Mattay, M Zamani, D Saturno, EV Loftus, MA Ciorba, A Yarur, S Singh, P DeepakFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.